Immune suppression in head and neck cancers: A review

Clinical and Developmental Immunology

Volumn 2010, Issue , 2010, Pages

  Saussez, Sven ^a,d   Duray, Analle ^a   Demoulin, Stéphanie ^b   Hubert, Pascale ^b   Delvenne, Philippe ^b,c  

^a UNIVERSITY OF MONS   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c FNRS   (Belgium)

^d SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1; PROSTAGLANDIN E2; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN A; VASCULOTROPIN B; VASCULOTROPIN D; HLA ANTIGEN;

ANTIGEN PRESENTING CELL; APOPTOSIS; CANCER EPIDEMIOLOGY; CANCER RADIOTHERAPY; CANCER RISK; CARCINOGENESIS; CELL FUNCTION; DENDRITIC CELL; EOSINOPHIL; HEAD AND NECK CARCINOMA; HISTOCOMPATIBILITY COMPLEX; HUMAN; IMMUNE DEFICIENCY; LANGERHANS CELL; MYELOID DENDRITIC CELL; PRIORITY JOURNAL; REVIEW; SQUAMOUS CELL CARCINOMA; T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE; WART VIRUS; ANIMAL; GENETICS; HEAD AND NECK TUMOR; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; MACROPHAGE; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOPHYSIOLOGY; TUMOR ESCAPE;

ANIMALS; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; HLA ANTIGENS; HUMANS; IMMUNOSUPPRESSION; MACROPHAGES; NEOVASCULARIZATION, PATHOLOGIC; T-LYMPHOCYTES; TUMOR ESCAPE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79955081407     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2010/701657     Document Type: Review

References (160)

1. Grandis J. R., Pietenpol J. A., Greenberger J. S., Pelroy R. A., Mohla S., Head and neck cancer: meeting summary and research opportunities Cancer Research 2004 64 21 8126 8129 (Pubitemid 39446952)
2. Shah J. P., Patel S. G., Head and Neck Surgery and Oncology 2003 New York, NY, USA Mosby
3. Forastiere A. A., Trotti A., Radiotherapy and concurrent chemotherapy: a strategy that improves locoregional control and survival in oropharyngeal cancer Journal of the National Cancer Institute 1999 91 24 2065 2066 (Pubitemid 30019565)
4. Denis F., Garaud P., Bardet E., Alfonsi M., Sire C., Germain T., Bergerot P., Rhein B., Tortochaux J., Calais G., Final results of the 94-01 French head and neck oncology and radiotherapy group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma Journal of Clinical Oncology 2004 22 1 69 76 (Pubitemid 41095116)
5. Adelstein D. J., Li Y., Adams G. L., Wagner H., Kish J. A., Ensley J. F., Schuller D. E., Forastiere A. A., An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer Journal of Clinical Oncology 2003 21 1 92 98
6. Al-Sarraf M., LeBlanc M., Giri P. G. S., Fu K. K., Cooper J., Vuong TE., Forastiere A. A., Adams G., Sakr W. A., Schuller D. E., Ensley J. F., Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099 Journal of Clinical Oncology 1998 16 4 1310 1317 (Pubitemid 28175745)
7. Jeremic B., Shibamoto Y., Milicic B., Nikolic N., Dagovic A., Aleksandrovic J., Vaskovic Z., Tadic L., Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial Journal of Clinical Oncology 2000 18 7 1458 1464 (Pubitemid 30205391)
8. Cooper J. S., Pajak T. F., Forastiere A. A., Jacobs J., Campbell B. H., Saxman S. B., Kish J. A., Kim H. E., Cmelak A. J., Rotman M., Machtay M., Ensley J. F., Chao C., Schultz C. J., Lee N., Fu K. K., Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck New England Journal of Medicine 2004 350 19 1937 1944
9. Bernier J., Domenge C., Ozsahin M., Matuszewska K., Lefbvre J.-L., Greiner R. H., Giralt J., Maingon P., Rolland F., Bolla M., Cognetti F., Bourhis J., Kirkpatrick A., Van Glabbeke M., Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck advanced head and neck cancer New England Journal of Medicine 2004 350 19 1945 1952 (Pubitemid 38580197)
10. Lang K., Menzin J., Earle C. C., Jacobson J., Hsu M. A., The economic cost of squamous cell cancer of the head and neck: findings from linked SEER-medicare data Archives of OtolaryngologyHead and Neck Surgery 2004 130 11 1269 1275 (Pubitemid 39532259)
11. Swann J. B., Smyth M. J., Immune surveillance of tumors Journal of Clinical Investigation 2007 117 5 1137 1146 (Pubitemid 46718398)
12. Gorochov G., Papo T., Immunologie 2000 Doin Groupe Liaisons
13. Costello R. T., Gastaut J. A., Olive D., Tumor escape from mmune surveillance Archivum Immunologiae et Therapiae Experimentalis 1999 47 2 83 88
14. Whiteside T. L., Tumor-induced death of immune cells: its mechanisms and consequences Seminars in Cancer Biology 2002 12 1 43 50 (Pubitemid 34087897)
15. Hoskin D. W., Mader J. S., Furlong S. J., Conrad D. M., Blay J., Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells International Journal of Oncology 2008 32 3 527 535 (Pubitemid 351330458)
16. Lewis C. E., Pollard J. W., Distinct role of macrophages in different tumor microenvironments Cancer Research 2006 66 2 605 612 (Pubitemid 43165918)
17. Lamagna C., Aurrand-Lions M., Imhof B. A., Dual role of macrophages in tumor growth and angiogenesis Journal of Leukocyte Biology 2006 80 4 705 713 (Pubitemid 44835885)
18. Coffelt S. B., Hughes R., Lewis C. E., Tumor-associated macrophages: effectors of angiogenesis and tumor progression Biochimica et Biophysica Acta 2009 1796 1 11 18
19. Mantovani A., Schioppa T., Porta C., Allavena P., Sica A., Role of tumor-associated macrophages in tumor progression and invasion Cancer and Metastasis Reviews 2006 25 3 315 322 (Pubitemid 44922352)
20. Sica A., Schioppa T., Mantovani A., Allavena P., Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy European Journal of Cancer 2006 42 6 717 727
21. Condeelis J., Pollard J. W., Macrophages: obligate partners for tumor cell migration, invasion, and metastasis Cell 2006 124 2 263 266 (Pubitemid 43121975)
22. Shih J.-Y., Yuan A., Chen J. J.-W., Yang P.-C., Tumor-associated macrophages: its role in cancer invasion and metastasis Journal of Cancer Molecules 2006 2 3 101 106
23. Siveen K. S., Kuttan G., Role of macrophages in tumour progression Immunology Letters 2009 123 2 97 102
24. Qian B. Z., Pollard J. W., Macrophage diversity enhances tumor progression and metastasis Cell 2010 141 1 39 51
25. Tsung K., Dolan J. P., Tsung Y. L., Norton J. A., Macrophages as effector cells in interleukin 12-induced T cell-dependent tumor rejection Cancer Research 2002 62 17 5069 5075 (Pubitemid 34984436)
26. Brigati C., Noonan D. M., Albini A., Benelli R., Tumors and inflammatory infiltrates: friends or foes? Clinical and Experimental Metastasis 2002 19 3 247 258 (Pubitemid 34553525)
27. Bingle L., Brown N. J., Lewis C. E., The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies Journal of Pathology 2002 196 3 254 265 (Pubitemid 34189413)
28. Leek R. D., Harris A. L., Tumor-associated macrophages in breast cancer Journal of Mammary Gland Biology and Neoplasia 2002 7 2 177 189 (Pubitemid 38420774)
29. Van Der Bij G. J., Oosterling S. J., Meijer S., Beelen R. H. J., Van Egmond M., The role of macrophages in tumor development Cellular Oncology 2005 27 4 203 213 (Pubitemid 43086474)
30. Ostrand-Rosenberg S., Immune surveillance: a balance between protumor and antitumor immunity Current Opinion in Genetics and Development 2008 18 1 11 18 (Pubitemid 351694442)
31. Bi Y., Liu G., Yang R., Th17 cell induction and immune regulatory effects Journal of Cellular Physiology 2007 211 2 273 278 (Pubitemid 46580080)
32. Viguier M., Lematre F., Verola O., Cho M. S., Gorochov G., Dubertret L., Bachelez H., Kourilsky P., Ferradini L., Foxp3 expressing CD4+CD25high regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells Journal of Immunology 2004 173 2 1444 1453 (Pubitemid 38924326)
33. Yang Z. Z., Ansell S. M., The role of T cells in the cancer immunological response American Journal of Immunology 2009 5 1 17 28
34. Curiel T. J., Coukos G., Zou L., Alvarez X., Cheng P., Mottram P., Evdemon-Hogan M., Conejo-Garcia J. R., Zhang L., Burow M., Zhu Y., Wei S., Kryczek I., Daniel B., Gordon A., Myers L., Lackner A., Disis M. L., Knutson K. L., Chen L., Zou W., Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival Nature Medicine 2004 10 9 942 949 (Pubitemid 39273735)
35. Salama P., Phillips M., Grieu F., Morris M., Zeps N., Joseph D., Platell C., Iacopetta B., Tumor-infiltrating Foxp3+ T regulatory cells show strong prognostic significance in colorectal cancer Journal of Clinical Oncology 2009 27 2 186 192
36. Huang B., Pan P. Y., Li Q., Sato A. I., Levy D. E., Bromberg J., Divino C. M., Chen S. H., Gr- 1 + CD 115 + immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host Cancer Research 2006 66 2 1123 1131 (Pubitemid 43165981)
37. Sinha P., Clements V. K., Bunt S. K., Albelda S. M., Ostrand-Rosenberg S., Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response Journal of Immunology 2007 179 2 977 983
38. Whiteside T. L., Immunobiology of head and neck cancer Cancer and Metastasis Reviews 2005 24 1 95 105 (Pubitemid 40576066)
39. Badoual C., Sandoval F., Pere H., Hans S., Gey A., Merillon N., Van Ryswick C., Quintin-Colonna F., Bruneval P., Brasnu D., Fridman W. H., Tartour E., Better understanding tumor-host interaction in head and neck cancer to improve the design and development of immunotherapeutic strategies Head and Neck 2010 32 7 946 958
40. Young M. R. I., Protective mechanisms of head and neck squamous cell carcinomas from immune assault Head and Neck 2006 28 5 462 470 (Pubitemid 43673082)
41. Ferris R. L., Hunt J. L., Ferrone S., Human leukocyte antigen (HLA) class I defects in head and neck cancer: molecular mechanisms and clinical significance Immunologic Research 2005 33 2 113 133 (Pubitemid 41457464)
42. Albers A., Abe K., Hunt J., Wang J., Lopez-Albaitero A., Schaefer C., Gooding W., Whiteside T. L., Ferrone S., DeLeo A., Ferris R. L., Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neck Cancer Research 2005 65 23 11146 11155 (Pubitemid 41713386)
43. Lpez-Albaitero A., Nayak J. V., Ogino T., Machandia A., Gooding W., DeLeo A. B., Ferrone S., Ferris R. L., Role of antigen-processing machinery in the in vitro resistance of squamous cell carcinoma of the head and neck cells to recognition by CTL Journal of Immunology 2006 176 6 3402 3409 (Pubitemid 43363987)
44. Hathaway B., Landsittel D. P., Gooding W., Whiteside T. L., Grandis J. R., Siegfried J. M., Bigbee W. L., Ferris R. L., Multiplexed analysis of serum cytokines as biomarkers in squamous cell carcinoma of the head and neck patients Laryngoscope 2005 115 3 522 527 (Pubitemid 40328005)
45. Hoffmann T. K., Bier H., Whiteside T. L., Targeting the immune system: novel therapeutic approaches in squamous cell carcinoma of the head and neck Cancer Immunology, Immunotherapy 2004 53 12 1055 1067 (Pubitemid 39506395)
46. Reichert T. E., Rabinowich H., Johnson J. T., Whiteside T. L., Mechanisms responsible for signaling and functional defects Journal of Immunotherapy 1998 21 4 295 306 (Pubitemid 28328409)
47. Young M. R. I., Wright M. A., Lozano Y., Matthews J. P., Benefield J., Prechel M. M., Mechanisms of immune suppression in patients with head and neck cancer: influence on the immune infiltrate of the cancer International Journal of Cancer 1996 67 3 333 338 (Pubitemid 26274122)
48. Hoffmann T. K., Dworacki G., Tsukihiro T., Meidenbauer N., Gooding W., Johnson J. T., Whiteside T. L., Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance Clinical Cancer Research 2002 8 8 2553 2562 (Pubitemid 34856339)
49. Saito T., Kuss I., Dworacki G., Gooding W., Johnson J. T., Whiteside T. L., Spontaneous ex vivo apoptosis of peripheral blood mononuclear cells in patients with head and neck cancer Clinical Cancer Research 1999 5 6 1263 1273 (Pubitemid 29282928)
50. Duffey D. C., Chen Z., Dong G., Ondrey F. G., Wolf J. S., Brown K., Siebenlist U., Van Waes C., Expression of a dominant-negative mutant inhibitor- B of nuclear factor- B in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo Cancer Research 1999 59 14 3468 3474 (Pubitemid 29334510)
51. Dasgupta S., Bhattacharya-Chatterjee M., O'Malley B. W. Jr., Chatterjee S. K., Recombinant vaccinia virus expressing interleukin-2 invokes anti-tumor cellular immunity in an orthotopic murine model of head and neck squamous cell carcinoma Molecular Therapy 2006 13 1 183 193 (Pubitemid 41763497)
52. Saussez S., Camby I., Toubeau G., Kiss R., Galectins as modulators of tumor progression in head and neck squamous cell carcinomas Head and Neck 2007 29 9 874 884 (Pubitemid 350303676)
53. Alhamarneh O., Amarnath S. M. P., Stafford N. D., Greenman J., Regulatory T cells: what role do they play in antitumor immunity in patients with head and neck cancer? Head and Neck 2008 30 2 251 261 (Pubitemid 351251710)
54. Jewett A., Head C., Cacalano N. A., Emerging mechanisms of immunosuppression in oral cancers Journal of Dental Research 2006 85 12 1061 1073 (Pubitemid 44935523)
55. Kross K. W., Heimdal J. H., Aarstad H. J., Mononuclear phagocytes in head and neck squamous cell carcinoma European Archives of Oto-Rhino-Laryngology 2010 267 3 335 344
56. Antoniou A. N., Powis S. J., Elliott T., Assembly and export of MHC class I peptide ligands Current Opinion in Immunology 2003 15 1 75 81 (Pubitemid 35454196)
57. Ferris R. L., Whiteside T. L., Ferrone S., Immune escape associated with functional defects in antigen-processing machinery in head and neck cancer Clinical Cancer Research 2006 12 13 3890 3895 (Pubitemid 44078071)
58. Ogino T., Shigyo H., Ishii H., Katayama A., Miyokawa N., Harabuchi Y., Ferrone S., HLA class I antigen down-regulation in primary laryngeal squamous cell carcinoma lesions as a poor prognostic marker Cancer Research 2006 66 18 9281 9289 (Pubitemid 44521150)
59. Grandis J. R., Falkner D. M., Melhem M. F., Gooding W. E., Drenning S. D., Morel P. A., Human leukocyte antigen class I allelic and haplotype loss in squamous cell carcinoma of the head and neck: clinical and immunogenetic consequences Clinical Cancer Research 2000 6 7 2794 2802 (Pubitemid 30482119)
60. Tourkova I. L., Shurin G. V., Chatta G. S., Perez L., Finke J., Whiteside T. L., Ferrone S., Shurin M. R., Restoration by IL-15 of MHC class I antigen-processing machinery in human dendritic cells inhibited by tumor-derived gangliosides Journal of Immunology 2005 175 5 3045 3052 (Pubitemid 41170523)
61. Steinbrink K., Mahnke K., Grabbe S., Enk A. H., Jonuleit H., Myeloid dendritic cell: from sentinel of immunity to key player of peripheral tolerance? Human Immunology 2009 70 5 289 293
62. Liu K., Nussenzweig M. C., Origin and development of dendritic cells Immunological Reviews 2010 234 1 45 54
63. Valladeau J., Saeland S., Cutaneous dendritic cells Seminars in Immunology 2005 17 4 273 283 (Pubitemid 40984021)
64. Charles J., Chaperot L., Salameire D., Di Domizio J., Aspord C., Gressin R., Jacob M. C., Richard M. J., Beani J. C., Plumas J., Leccia M. T., Plasmacytoid dendritic cells and dermatological disorders: focus on their role in autoimmunity and cancer European Journal of Dermatology 2010 20 1 16 23
65. Cella M., Sallusto F., Lanzavecchia A., Origin, maturation and antigen presenting function of dendritic cells Current Opinion in Immunology 1997 9 1 10 16 (Pubitemid 27095893)
66. Hawiger D., Inaba K., Dorsett Y., Guo M., Mahnke K., Rivera M., Ravetch J. V., Steinman R. M., Nussenzweig M. C., Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo Journal of Experimental Medicine 2001 194 6 769 779 (Pubitemid 32983013)
67. Yamazaki S., Inaba K., Tarbell K. V., Steinman R. M., Dendritic cells expand antigen-specific Foxp3+ CD25+CD4+ regulatory T cells including suppressors of alloreactivity Immunological Reviews 2006 212 314 329 (Pubitemid 44116717)
68. Jonuleit H., Schmitt E., Schuler G., Knop J., Enk A. H., Induction of interleukin 10-producing, nonproliferating CD4+ T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells Journal of Experimental Medicine 2000 192 9 1213 1222
69. Barrett A. W., Cruchley A. T., Williams D. M., Oral mucosal Langerhans' cells Critical Reviews in Oral Biology and Medicine 1996 7 1 36 58 (Pubitemid 26154805)
70. Cruchley A. T., Williams D. M., Farthing P. M., Speight P. M., Lesch C. A., Squier C. A., Langerhans cell density in normal human oral mucosa and skin: relationship to age, smoking and alcohol consumption Journal of Oral Pathology and Medicine 1994 23 2 55 59 (Pubitemid 2054217)
71. Barett A. W., Williams D. M., Scott J., Effect of tobacco and alcohol consumption on the Langerhans cell population of human lingual epithelium determined using a monoclonal antibody against HLADR Journal of Oral Pathology and Medicine 1991 20 2 49 52
72. Daniels T. E., Chou L., Greenspan J. S., Grady D. G., Hauck W. W., Greene J. C., Ernster V. L., Reduction of Langerhans cells in smokeless tobacco-associated oral mucosal lesions Journal of Oral Pathology and Medicine 1992 21 3 100 104
73. Boyle J. O., Gm Z. H., Kacker A., Choksi V. L., Bocker J. M., Zhou XI. K., Yantiss R. K., Hughes D. B., Du B., Judson B. L., Subbaramaiah K., Dannenberg A. J., Effects of cigarette smoke on the human oral mucosal transcriptome Cancer Prevention Research 2010 3 3 266 278
74. Girod S. C., Khnast T., Ulrich S., Krueger G. R. F., Langerhans cells in epithelial tumors and benign lesions of the oropharynx In Vivo 1994 8 4 543 547 (Pubitemid 24341131)
75. Thompson A. C., Griffin N. R., Langerhans cells in normal and pathological vocal cord mucosa Acta Oto-Laryngologica 1995 115 6 830 832
76. Albuquerque R. L. C. Jr., Miguel M. C. C., Costa A. L. L., Souza L. B., Correlation of c-erbB-2 and S-100 expression with the malignancy grading and anatomical site in oral squamous cell carcinoma International Journal of Experimental Pathology 2003 84 6 259 265 (Pubitemid 38221804)
77. Yilmaz T., Gedikoglu G., elik A., nerci M., Turan E., Prognostic significance of Langerhans cell infiltration in cancer of the larynx OtolaryngologyHead and Neck Surgery 2005 132 2 309 316 (Pubitemid 40431150)
78. Ma C. X., Jia T. C., Li X. R., Zhand Z. F., Yiao C. B., Langerhans cells in nasopharyngeal carcinoma in relation to prognosis In Vivo 1995 9 3 225 229
79. Gallo O., Libonati G. A., Gallina E., Fini-Storchi O., Giannini A., Urso C., Bondi R., Langerhans cells related to prognosis in patients with laryngeal carcinoma Archives of OtolaryngologyHead and Neck Surgery 1991 117 9 1007 1010
80. Li X., Takahashi Y., Sakamoto K., Nakashima T., Expression of dendritic cell phenotypic antigens in cervical lymph nodes of patients with hypopharyngeal and laryngeal carcinoma The Journal of Laryngology and Otology. Supplement 2009 31 5 10
81. Strauss L., Volland D., Kunkel M., Reichert T. E., Dual role of VEGF family members in the pathogenesis of head and neck cancer (HNSCC): possible link between angiogenesis and immune tolerance Medical Science Monitor 2005 11 8 280 292
82. Kikuchi K., Kusama K., Sano M., Nakanishi Y., Ishige T., Ohni S., Oinuma T., Nemoto N., Vascular endothelial growth factor and dendritic cells in human squamous cell carcinoma of the oral cavity Anticancer Research 2006 26 3A 1833 1848 (Pubitemid 43989440)
83. Kikuchi K., Kusama K., Taguchi K., Ishikawa F., Okamoto M., Shimada J., Sakashita H., Yamamoto Y., Dendritic cells in human squamous cell carcinoma of the oral cavity Anticancer Research 2002 22 2A 545 557 (Pubitemid 34475200)
84. Wei N., Tahan S. R., S100+ cell response to squamous cell carcinoma of the lip: inverse correlation with metastasis Journal of Cutaneous Pathology 1998 25 9 463 468 (Pubitemid 28474805)
85. Pries R., Wulff S., Wollenberg B., Toll-like receptor modulation in head and neck cancer Critical Reviews in Immunology 2008 28 3 201 213
86. Frenzel H., Hoffmann B., Brocks C., Schlenke P., Pries R., Wollenberg B., Toll-like receptor interference in myeloid dendritic cells through head and neck cancer Anticancer Research 2006 26 6B 4409 4413 (Pubitemid 46031515)
87. Hoffmann T. K., Mller-Berghaus J., Ferris R. L., Johnson J. T., Storkus W. J., Whiteside T. L., Alterations in the frequency of dendritic cell subsets in the peripheral circulation of patients with squamous cell carcinomas of the head and neck Clinical Cancer Research 2002 8 6 1787 1793 (Pubitemid 34633736)
88. Colonna M., Trinchieri G., Liu Y. J., Plasmacytoid dendritic cells in immunity Nature Immunology 2004 5 12 1219 1226 (Pubitemid 41057736)
89. Hartmann E., Wollenberg B., Rothenfusser S., Wagner M., Wellisch D., Mack B., Giese T., Gires O., Endres S., Hartmann G., Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer Cancer Research 2003 63 19 6478 6487 (Pubitemid 37255200)
90. Bekeredjian-Ding I., Schfer M., Hartmann E., Pries R., Parcina M., Schneider P., Giese T., Endres S., Wollenberg B., Hartmann G., Tumour-derived prostaglandin E and transforming growth factor- synergize to inhibit plasmacytoid dendritic cell-derived interferon- Immunology 2009 128 3 439 450
91. Auger M. J., Ross J. A., Lewis C. E., McGee J. O., The bilogy of macrophage The Macrophage 1992 Oxford, UK Oxford University Press 2 74
92. Li C., Shintani S., Terakado N., Nakashiro K. I., Hamakawa H., Infiltration of tumor-associated macrophages in human oral squamous cell carcinoma Oncology Reports 2002 9 6 1219 1223
93. Ritt M., De Andrea M., Mondini M., Mazibrada J., Giordano C., Pecorari G., Garzaro M., Landolfo V., Schena M., Chiusa L., Landolfo S., Cell cycle and viral and immunologic profiles of head and neck squamous cell carcinoma as predictable variables of tumor progression Head and Neck 2009 31 3 318 327
94. Brdos H., Juhsz A., Rpssy G., dny R., Fibrin deposition in squamous cell carcinomas of the larynx and hypopharynx Thrombosis and Haemostasis 1998 80 5 767 772
95. Salven P., Heikkil P., Anttonen A., Kajanti M., Joensuu H., Vascular endothelial growth factor in squamous cell head and neck carcinoma: expression and prognostic significance Modern Pathology 1997 10 11 1128 1133 (Pubitemid 27521291)
96. Neuchrist C., Quint C., Pammer A., Burian M., Vascular endothelial growth factor (VEGF) and microvessel density in squamous cell carcinomas of the larynx: an immunohistochemical study Acta Oto-Laryngologica 1999 119 6 732 738 (Pubitemid 29513788)
97. Lalla R. V., Boisoneau D. S., Spiro J. D., Kreutzer D. L., Expression of vascular endothelial growth factor receptors on tumor cells in head and neck squamous cell carcinoma Archives of OtolaryngologyHead and Neck Surgery 2003 129 8 882 888 (Pubitemid 36966435)
98. Liss C., Fekete M. J., Hasina R., Diemthuy Lam C., Lingen M. W., Paracrine angiogenic loop between head-and-neck squamous-cell carcinomas and macrophages International Journal of Cancer 2001 93 6 781 785 (Pubitemid 32756746)
99. Liu S. Y., Chang L. C., Pan L. F., Hung Y. J., Lee C. H., Shieh Y. S., Clinicopathologic significance of tumor cell-lined vessel and microenvironment in oral squamous cell carcinoma Oral Oncology 2008 44 3 277 285
100. Marcus B., Arenberg D., Lee J., Kleer C., Chepeha D. B., Schmalbach C. E., Islam M., Paul S., Pan Q., Hanash S., Kuick R., Merajver S. D., Teknos T. N., Prognostic factors in oral cavity and oropharyngeal squamous cell carcinoma: the impact of tumor-associated macrophages Cancer 2004 101 12 2779 2787 (Pubitemid 39603186)
101. Abbas A. K., Lichtman A. H., Les Bases de Limmunologie Fondamentale et Clinique 2005 Elsevier
102. Bergmann C., Strauss L., Zeidler R., Lang S., Whiteside T. L., Expansion and characteristics of human T regulatory type 1 cells in co-cultures simulating tumor microenvironment Cancer Immunology, Immunotherapy 2007 56 9 1429 1442 (Pubitemid 47024702)
103. Gastman B. R., Atarashi Y., Reichert T. E., Saito T., Balkir L., Rabinowich H., Whiteside T. L., Fas ligand is expressed on human squamous cell carcinomas of the head and neck, and it promotes apoptosis of T lymphocytes Cancer Research 1999 59 20 5356 5364 (Pubitemid 29504005)
104. Gastman B. R., Johnson D. E., Whiteside T. L., Rabinowich H., Tumor-induced apoptosis of T lymphocytes: elucidation of intracellular apoptotic events Blood 2000 95 6 2015 2023 (Pubitemid 30151640)
105. Gastman B. R., Yin X. M., Johnson D. E., Wieckowski E., Wang G. Q., Watkins S. C., Rabinowich H., Tumor-induced apoptosis of T cells: amplification by a mitochondrial cascade Cancer Research 2000 60 24 6811 6817 (Pubitemid 32059143)
106. Kassouf N., Thornhill M. H., Oral cancer cell lines can use multiple ligands, including Fas-L, TRAIL and TNF-, to induce apoptosis in Jurkat T cells: possible mechanisms for immune escape by head and neck cancers Oral Oncology 2008 44 7 672 682 (Pubitemid 351842819)
107. Bergmann C., Strauss L., Wieckowski E., Czystowska M., Albers A., Wang Y., Zeidler R., Lang S., Whiteside T. L., Tumor-derived microvesicles in sera of patients with head and neck cancer and their role in tumor progression Head and Neck 2009 31 3 371 380
108. Kim J. W., Wieckowski E., Taylor D. D., Reichert T. E., Watkins S., Whiteside T. L., Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes Clinical Cancer Research 2005 11 3 1010 1020 (Pubitemid 40175748)
109. Kim J. W., Tsukishiro T., Johnson J. T., Whiteside T. L., Expression of pro- and antiapoptotic proteins in circulating CD8+ T cells of patients with squamous cell carcinoma of the head and neck Clinical Cancer Research 2004 10 15 5101 5110 (Pubitemid 39099784)
110. Klatka J., Roliski J., Kupisz K., Klonowski S., Skomra D., Expression of bcl-2 protein in lymphocytes of patients with laryngeal carcinoma European Archives of Oto-Rhino-Laryngology 1999 256 6 299 302 (Pubitemid 29376268)
111. Strauss L., Bergmann C., Whiteside T. L., Human circulating CD4+CD25high Foxp3+ regulatory T cells kill autologous CD8 + but not CD4 + responder cells by Fas-mediated apoptosis Journal of Immunology 2009 182 3 1469 1480
112. Mandapathil M., Szczepanski M. J., Szajnik M., Ren J., Lenzner D. E., Jackson E. K., Gorelik E., Lang S., Johnson J. T., Whiteside T. L., Increased ectonucleotidase expression and activity in regulatory T cells of patients with head and neck cancer Clinical Cancer Research 2009 15 20 6348 6357
113. Bergmann C., Strauss L., Wang Y., Szczepanski M. J., Lang S., Johnson J. T., Whiteside T. L., T regulatory type 1 cells in squamous cell carcinoma of the head and neck: mechanisms of suppression and expansion in advanced disease Clinical Cancer Research 2008 14 12 3706 3715
114. Badoual C., Hans S., Rodriguez J., Peyrard S., Klein C., Agueznay N. E. H., Mosseri V., Laccourreye O., Bruneval P., Fridman W. H., Brasnu D. F., Tartour E., Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers Clinical Cancer Research 2006 12 2 465 472 (Pubitemid 43166137)
115. Zhang Y. L., Li J., Mo H. Y., Qiu F., Zheng LI. M., Qian C. N., Zeng YI. X., Different subsets of tumor infiltrating lymphocytes correlate with NPC progression in different ways Molecular Cancer 2010 9, article 4
116. Loose D., Signore A., Bonanno E., Vermeersch H., Dierckx R., Deron P., Van De Wiele C., Prognostic value of CD25 expression on lymphocytes and tumor cells in squamous-cell carcinoma of the head and neck Cancer Biotherapy and Radiopharmaceuticals 2008 23 1 25 33 (Pubitemid 351304209)
117. Strauss L., Bergmann C., Szczepanski M., Gooding W., Johnson J. T., Whiteside T. L., A unique subset of CD4+CD25high Foxp3+ T cells secreting interleukin-10 and transforming growth factor- 1 mediates suppression in the tumor microenvironment Clinical Cancer Research 2007 13 15 4345 4354 (Pubitemid 47219698)
118. Gabriel A., Namysowski G., Zikowski A., Morawski K., Steplewska-Mazur K., Urbaniec P., Immunohistochemical analysis of lymphocytic infiltration in the tumor microenvironment in patients operated on for laryngeal cancer European Archives of Oto-Rhino-Laryngology 1999 256 8 384 387 (Pubitemid 29472184)
119. Whiteside T. L., Down-regulation of -chain expression in T cells: a biomarker of prognosis in cancer? Cancer Immunology, Immunotherapy 2004 53 10 865 878 (Pubitemid 39312654)
120. Reichert T. E., Day R., Wagner E. M., Whiteside T. L., Absent or low expression of the chain in T cells at the tumor site correlates with poor survival in patients with oral carcinoma Cancer Research 1998 58 23 5344 5347 (Pubitemid 28551114)
121. Whiteside T. L., Signaling defects in T lymphocytes of patients with malignancy Cancer Immunology Immunotherapy 1999 48 7 346 352 (Pubitemid 29461386)
122. Kuss I., Saito T., Johnson J. T., Whiteside T. L., Clinical significance of decreased chain expression in peripheral blood lymphocytes of patients with head and neck cancer Clinical Cancer Research 1999 5 2 329 334 (Pubitemid 29085186)
123. Pignataro L., Pagani D., Brando B., Sambataro G., Scarpati B., Corsi M. M., Down-regulation of chain and zeta-associated protein 70 (Zap 70) expression in circulating T lymphocytes in laryngeal squamous cell carcinoma Analytical and Quantitative Cytology and Histology 2007 29 1 57 62 (Pubitemid 46333522)
124. Reichert T. E., Scheuer C., Day R., Wagner W., Whiteside T. L., The number of intratumoral dendritic cells and -chain expression in T cells as prognostic and survival biomarkers in patients with oral carcinoma Cancer 2001 91 11 2136 2147 (Pubitemid 32476379)
125. Distel L. V., Fickenscher R., Dietel K., Hung A., Iro H., Zenk J., Nkenke E., Bttner M., Niedobitek G., Grabenbauer G. G., Tumour infiltrating lymphocytes in squamous cell carcinoma of the oro- and hypopharynx: prognostic impact may depend on type of treatment and stage of disease Oral Oncology 2009 45 10 e167 e174
126. Dorta R. G., Landman G., Kowalski L. P., Lauris J. R. P., Latorre M. R. D. O., Oliveira D. T., Tumour-associated tissue eosinophilia as a prognostic factor in oral squamous cell carcinomas Histopathology 2002 41 2 152 157 (Pubitemid 34985188)
127. Goldsmith M. M., Belchis D. A., Cresson D. H., Merritt W. D., Askin F. B., The importance of the eosinophil in head and neck cancer OtolaryngologyHead and Neck Surgery 1992 106 1 27 33
128. Horiuchi K., Mishima K., Ohsawa M., Sugimura M., Aozasa K., Prognostic factors for well-differentiated squamous cell carcinoma in the oral cavity with emphasis on immunohistochemical evaluation Journal of Surgical Oncology 1993 53 2 92 96 (Pubitemid 23164594)
129. Said M., Wiseman S., Yang J., Alrawi S., Douglas W., Cheney R., Hicks W., Rigual N., Loree T., Spiegel G., Tan D., Tissue eosinophilia: a morphologic marker for assessing stromal invasion in laryngeal squamous neoplasms BMC Clinical Pathology 2005 5, article 1
130. Falconieri G., Luna M. A., Pizzolitto S., DeMaglio G., Angione V., Rocco M., Eosinophil-rich squamous carcinoma of the oral cavity: a study of 13 cases and delineation of a possible new microscopic entity Annals of Diagnostic Pathology 2008 12 5 322 327
131. Tostes Oliveira D., Tjioe K. C., Assao A., Sita Faustino S. E., Lopes Carvalho A., Landman G., Kowalski L. P., Tissue eosinophilia and its association with tumoral invasion of oral cancer International Journal of Surgical Pathology 2009 17 3 244 249
132. Tadbir A. A., Ashraf M. J., Sardari Y., Prognostic significance of stromal eosinophilic infiltration in oral squamous cell carcinoma Journal of Craniofacial Surgery 2009 20 2 287 289
133. Leighton S. E. J., Teo J. G. C., Leung S. F., Cheung A. Y. K., Lee J. C. K., Van Hasselt C. A., Prevalence and prognostic significance of tumor-associated tissue eosinophilia in nasopharyngeal carcinoma Cancer 1996 77 3 436 440 (Pubitemid 26047563)
134. Manchanda P., Sharma S. C., Das S. N., Differential regulation of IL-2 and IL-4 in patients with tobacco-related oral squamous cell carcinoma Oral Diseases 2006 12 5 455 462 (Pubitemid 44252537)
135. Riedel F., Adam S., Feick P., Haas S., Gtte K., Hrmann K., Expression of IL-18 in patients with head and neck squamous cell carcinoma International Journal of Molecular Medicine 2004 13 2 267 272
136. Sparano A., Lathers D. M. R., Achille N., Petruzzelli G. J., Young M. R. I., Modulation of Th1 and Th2 cytokine profiles and their association with advanced head and neck squamous cell carcinoma OtolaryngologyHead and Neck Surgery 2004 131 5 573 576 (Pubitemid 39446277)
137. Lau K. M., Cheng S. H., Lo K. W., Lee S. A. K. W., Woo J. K. S., Van Hasselt C. A., Lee S. P., Rickinson A. B., Ng M. H. L., Increase in circulating Foxp3+ CD4+CD25high regulatory T cells in nasopharyngeal carcinoma patients British Journal of Cancer 2007 96 4 617 622
138. Schaefer C., Kim G. G., Albers A., Hoermann K., Myers E. N., Whiteside T. L., Characteristics of CD4+CD25+ regulatory T cells in the peripheral circulation of patients with head and neck cancer British Journal of Cancer 2005 92 5 913 920 (Pubitemid 40462639)
139. Schwarz S., Butz M., Morsczeck C., Reichert T. E., Driemel O., Increased number of CD25+ Foxp3+ regulatory T cells in oral squamous cell carcinomas detected by chromogenic immunohistochemical double staining Journal of Oral Pathology and Medicine 2008 37 8 485 489
140. Strauss L., Bergmann C., Gooding W., Johnson J. T., Whiteside T. L., The frequency and suppressor function of CD4+CD25high Foxp3+ T cells in the circulation of patients with squamous cell carcinoma of the head and neck Clinical Cancer Research 2007 13 21 6301 6311 (Pubitemid 350075018)
141. Dahlstrand H., Nsman A., Romanitan M., Lindquist D., Ramqvist T., Dalianis T., Human papillomavirus accounts both for increased incidence and better prognosis in tonsillar cancer Anticancer Research 2008 28 2B 1133 1138 (Pubitemid 351578850)
142. Rosenquist K., Wennerberg J., Annertz K., Schildt E.-B., Hansson B. G., Bladstrm A., Andersson G., Recurrence in patients with oral and oropharyngeal squamous cell carcinoma: human papillomavirus and other risk factors Acta Oto-Laryngologica 2007 127 9 980 987 (Pubitemid 47345810)
143. Lindel K., Beer K. T., Laissue J., Greiner R. H., Aebersold D. M., Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma Cancer 2001 92 4 805 813 (Pubitemid 32783066)
144. Lindquist D., Romanitan M., Hammarstedt L., Nsman A., Dahlstrand H., Lindholm J., Onelv L., Ramqvist T., Ye W., Munck-Wikland E., Dalianis T., Human papillomavirus is a favourable prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7 Molecular Oncology 2007 1 3 350 355 (Pubitemid 350186274)
145. Fakhry C., Westra W. H., Li S., Cmelak A., Ridge J. A., Pinto H., Forastiere A., Gillison M. L., Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial Journal of the National Cancer Institute 2008 100 4 261 269 (Pubitemid 351480538)
146. Weinberger P. M., Yu Z., Haffty B. G., Kowalski D., Harigopal M., Brandsma J., Sasaki C., Joe J., Camp R. L., Rimm D. L., Psyrri A., Molecular classification identifies a subset of human papillomavirus- associated oropharyngeal cancers with favorable prognosis Journal of Clinical Oncology 2006 24 5 736 747 (Pubitemid 46622040)
147. Hennessey P. T., Westra W. H., Califano J. A., Human papillomavirus and head and neck squamous cell carcinoma: recent evidence and clinical implications Journal of Dental Research 2009 88 4 300 306
148. Kumar B., Cordell K. G., Lee J. S., Worden F. P., Prince M. E., Tran H. H., Wolf G. T., Urba S. G., Chepeha D. B., Teknos T. N., Eisbruch A., Tsien C. I., Taylor J. M. G., D'Silva N. J., Yang K., Kurnit D. M., Bauer J. A., Bradford C. R., Carey T. E., EGFR, p16, HPV titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer Journal of Clinical Oncology 2008 26 19 3128 3137
149. Rosenquist K., Risk factors in oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden Swedish Dental Journal. Supplement 2005 179 1 66
150. Hansson B. G., Rosenquist K., Antonsson A., Wennerberg J., Schildt E.-B., Bladstrm A., Andersson G., Strong association between infection with human papillomavirus and oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden Acta Oto-Laryngologica 2005 125 12 1337 1344 (Pubitemid 41722001)
151. Morshed K., Association between human papillomavirus infection and laryngeal squamous cell carcinoma Journal of Medical Virology 2010 82 6 1017 1023
152. Bozdayi G., Kemaloglu Y., Ekinci O., Dogan B., Ilhan M. N., Aydil U., Akyol G., Koybasioglu A., Inal E., Rota S., Role of human papillomavirus in the clinical and histopathologic features of laryngeal and hypopharyngeal cancers Journal of OtolaryngologyHead and Neck Surgery 2009 38 1 119 125
153. Yang S. W., Lee Y. S., Chen T. A., Wu C. J., Tsai C. N., Human papillomavirus in oral leukoplakia is no prognostic indicator of malignant transformation Cancer Epidemiology 2009 33 2 118 122
154. Morshed K., Korobowicz E., Szymaski M., Skomra D., Golabek W., Immunohistochemical demonstration of multiple HPV types in laryngeal squamous cell carcinoma European Archives of Oto-Rhino-Laryngology 2005 262 11 917 920 (Pubitemid 41779884)
155. Aaltonen L. M., Wahlstrm T., Rihkanen H., Vaheri A., A novel method to culture laryngeal human papillomavirus-positive epithelial cells produces papilloma-type cytology on collagen rafts European Journal of Cancer 1998 34 7 1111 1116 (Pubitemid 28308355)
156. Ernoux-Neufcoeur P., Arafa M., Decaestecker C., Duray A., Remmelink M., Leroy X., Herfs M., Somja J., Depuydt C. E., Delvenne P., Saussez S., Combined analysis of HPV DNA, p16, p21 and p53 to predict prognosis in patients with stage IV hypopharyngeal carcinoma Journal of Cancer Research and Clinical Oncology 2010 137 1 173 181
157. Stanley M. A., Immune responses to human papilloma viruses Indian Journal of Medical Research 2009 130 3 266 276
158. Albers A., Abe K., Hunt J., Wang J., Lopez-Albaitero A., Schaefer C., Gooding W., Whiteside T. L., Ferrone S., DeLeo A., Ferris R. L., Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neck Cancer Research 2005 65 23 11146 11155 (Pubitemid 41713386)
159. Hoffmann T. K., Arsov C., Schirlau K., Bas M., Friebe-Hoffmann U., Klussmann J. P., Scheckenbach K., Balz V., Bier H., Whiteside T. L., T cells specific for HPV16 E7 epitopes in patients with squamous cell carcinoma of the oropharynx International Journal of Cancer 2006 118 8 1984 1991
160. Williams R., Lee D. W., Elzey B. D., Anderson M. E., Hostager B. S., Lee J. H., Preclinical models of HPV+ and HPV- HNSCC in mice: an immune clearance of HPV+ HNSCC Head and Neck 2009 31 7 911 918